Masimo | MASI - Los Gastos Financieros De La Deuda



Los Gastos Financieros De La Deuda Cambio Fecha
Abbott USD 297M 2M 2026-09
Accuray USD 2.88M 72K 2024-12
Align Technology USD 9.96M 3.02M 2026-06
AngioDynamics USD 102K 2K 2025-09
Artivion USD 5.53M 589K 2025-12
AtriCure USD 1.2M 15K 2026-06
Baxter International USD 64M 14M 2026-06
Becton, Dickinson and Co. USD 130M 2M 2026-09
Boston Scientific USD 100M 4M 2026-09
Dexcom USD 3.1M 100K 2026-09
Edwards Lifesciences USD 30M 5.9M 2026-06
General Electric Aerospace USD 231M 265M 2026-09
Globus Medical USD 5.53B 39.93M 2026-09
Haemonetics USD 5.08M 2.32M 2026-03
Inogen 1.03M 384K 2025-03
Insulet USD 12.3M 1.3M 2026-09
Integra LifeSciences USD 22.96M 33K 2026-09
Intuitive Surgical USD 19.35B 1.53B 2026-09
Medtronic USD 186M 10M 2026-06
Orthofix International 4.68M 731K 2025-09
Owens Minor USD 27.93M 1.1M 2025-12
ResMed USD 8.79M 14.55M 2025-09
Steris USD 11.2M 4.6M 2026-09
Stryker USD 47.25B 683M 2026-09
Tandem Diabetes Care USD 1.16B 5.29M 2026-09
Teleflex USD 21.21M 6.75M 2026-09
Thermo Fisher Scientific USD 417M 63M 2026-09
Zimmer Biomet Holdings USD 23.54B 740.8M 2026-09